SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-010491
Filing Date
2020-08-13
Accepted
2020-08-13 07:48:28
Documents
101
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q jagx-20200630x10q.htm 10-Q 2353085
2 EX-10.11 jagx-20200630ex1011b79cb.htm EX-10.11 109613
3 EX-10.12 jagx-20200630ex101286fcb.htm EX-10.12 51370
4 EX-10.13 jagx-20200630ex10134ea61.htm EX-10.13 23146
5 EX-31.1 jagx-20200630ex311680aff.htm EX-31.1 10992
6 EX-31.2 jagx-20200630ex3126b383b.htm EX-31.2 10991
7 EX-32.1 jagx-20200630ex3215ccda4.htm EX-32.1 6938
8 EX-32.2 jagx-20200630ex3224e7761.htm EX-32.2 6913
  Complete submission text file 0001558370-20-010491.txt   12889029

Data Files

Seq Description Document Type Size
9 EX-101.INS jagx-20200630.xml EX-101.INS 2525466
10 EX-101.SCH jagx-20200630.xsd EX-101.SCH 125035
11 EX-101.CAL jagx-20200630_cal.xml EX-101.CAL 61147
12 EX-101.DEF jagx-20200630_def.xml EX-101.DEF 655270
13 EX-101.LAB jagx-20200630_lab.xml EX-101.LAB 903003
14 EX-101.PRE jagx-20200630_pre.xml EX-101.PRE 850768
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36714 | Film No.: 201097254
SIC: 2834 Pharmaceutical Preparations